About Andrew Feigin

Andrew Feigin, MD
Chief Medical Officer
Professor of Neurology, NYU Langone Health
Co-Director, Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders

Andrew Feigin, a professor of Neurology at NYU Langone Health and co-director of the Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders, has been involved in HD clinical research since his participation in the Venezuela Collaborative Research Group which isolated the HD gene in 1993. Dr. Feigin’s independent research has focused on the development of novel imaging biomarkers that could be used as outcome measures for HD clinical trials, and he has had leadership roles in many HD clinical trials including LEGATO, SIGNAL, and PROOF-HD.  He has served as a member of HSG’s Executive Committee, chair of HSG’s Program Committee for the Peter Como HD Clinical Research Symposium, and chair of the HSG from 2018-2022. He currently serves as Chief Medical Officer for HSGCR.

Fun Fact: “I play tennis regularly and blow off steam doing the NY Times crossword puzzles.”